Have any clinical studies been done for Loma Lux® Psoriasis?
Clinical studies of 86 psoriasis subjects given oral doses of nickel sulfate and sodium bromide, two principal ingredients of Loma Lux® Psoriasis, indicate a high degree of statistical significance in the improvement in psoriasis area and severity measurements (PASI score). Ninety-eight percent of subjects exhibited a moderate to marked improvement. A double blind placebo controlled study confirmed safety and efficacy, employing nickel and bromide from a nickel bromide source.
